A professor at Harvard and core member of the Broad Institute, David Liu pioneered the groundbreaking technologies that allow scientists to make precise changes to DNA. His innovations have opened the door to potential cures for a wide range of genetic diseases. Liu received the 2025 Breakthrough Prize in Life Sciences winner and the 2022 King Faisal Prize in Medicine.

In this fireside chat, Liu reflects on the scientific breakthroughs behind these advances, their real-world impact, and how they're reshaping the future of medicine.

Aging is emerging as one of the most dynamic frontiers in biomedical research.

This panel explores how scientists are uncovering the mechanisms that drive age-related decline — and how that knowledge could lead to breakthroughs that slow, prevent, or even reverse aspects of aging.

Experts will discuss the latest research aimed at extending not just lifespan, but healthspan, and what these advances mean for the future of medicine.

Cancer diagnoses are rising at an alarming rate among adults under 55, a trend that could reshape the landscape of oncology.

This panel explores the surge in early-onset cancers and unpacks the complex web of contributing factors, including diet and lifestyle, and environmental exposures.

Panelists will also examine how these shifting trends are influencing approaches to prevention, diagnosis, and long-term care.

With remarks from Raj Hazarika, Chief Medical Officer for Commercial Products, Point32Health, the parent company of Harvard Pilgrim Health Care

Meet the next generation of scientists, founders, and visionaries redefining what’s possible in health and biotech.

This panel spotlights rising changemakers who are translating bold ideas into real-world impact. Hear how they’re navigating discovery, risk, and purpose at the cutting edge of science.

Emergency physician and public health expert Dr. Jeremy Faust offers an unflinching look at the state of public health in America, and what the future demands.

As the country grapples with growing health inequities, rising misinformation, and a rapidly shifting healthcare landscape, Dr. Faust — joined by Globe reporter Jessica Bartlett — explores how medicine is evolving not just within hospital walls, but through advances in technology, communication, and public policy.

A diabetes treatment turned household name, Ozempic and other GLP-1 drugs are reshaping not only obesity care, but the way we think about chronic disease, longevity, even food systems and addiction.

This panel explores the sweeping implications of the Ozempic era — from clinical breakthroughs and ethical questions to access, equity, and pharmaceutical power. Hear from leading experts as they unpack what these drugs mean for the future of medicine.

Complimentary lunch will be provided from 12:00 PM - 1:30 PM onsite.

Opening remarks for lunch will be offered by Tom Smith, EVP and Chief Medical Officer of Collegium.

Robert Langer is a Co-Founder of Moderna and one of nine Institute Professors at MIT. A prolific inventor, his research and patents has fueled the launch of countless biotech ventures, shaping the future of medicine. With over 220 major awards and 45 honorary doctorates, Langer has built a career at the intersection of science and entrepreneurship.

In this fireside chat with Business Reporter and author of Bold Types, a weekly roundup of Boston movers and shakers, Jon Chesto, they discuss the next big opportunities in health and biotech.